2002 Interim Report

	FAR EAST PHARMACEUTICAL TECHNOLOGY COMPANY LIMITED (399)

COVER RESULTS CONDENSED CONSOLIDATED INCOME STATEMENT CONDENSED CONSOLIDATED BALANCE SHEET CONDENSED CONSOLIDATED CASH FLOW STATEMENT CONDENSED CONSOLIDATED STATEMENT OF CHANGES IN EQUITY (UNAUDITED) NOTES TO THE FINANCIAL STATEMENTS MANAGEMENT DISCUSSION AND ANALYSIS FINANCIAL REVIEW CAPITAL STRUCTURE ANALYSIS OF TURNOVER EXPENSES FUTURE PROSPECTS CHARGES ON THE GROUP'S ASSETS EMPLOYEES SHARE OPTION SCHEME PURCHASE, SALE OR REDEMPTION OF SECURITIES AUDIT COMMITTEE DIRECTORS' INTERESTS IN SHARE CAPITAL AND WARRANTS SUBSTANTIAL SHAREHOLDERS CODE OF BEST PRACTICE